Last reviewed · How we verify
Trivalent Influenza Vaccine intradermal dose
Trivalent Influenza Vaccine intradermal dose is a Biologic drug developed by Seqirus. It is currently in Phase 1 development.
At a glance
| Generic name | Trivalent Influenza Vaccine intradermal dose |
|---|---|
| Sponsor | Seqirus |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children (PHASE1, PHASE2)
- Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years (PHASE1)
- Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients (PHASE3)
- Safety of 4Fluart ID Suspension for Injection in Adult Subjects (PHASE1)
- Two-site Intradermal Influenza Vaccination in Elderly (NA)
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study (NA)
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot (EARLY_PHASE1)
- Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Trivalent Influenza Vaccine intradermal dose CI brief — competitive landscape report
- Trivalent Influenza Vaccine intradermal dose updates RSS · CI watch RSS
- Seqirus portfolio CI
Frequently asked questions about Trivalent Influenza Vaccine intradermal dose
What is Trivalent Influenza Vaccine intradermal dose?
Trivalent Influenza Vaccine intradermal dose is a Biologic drug developed by Seqirus.
Who makes Trivalent Influenza Vaccine intradermal dose?
Trivalent Influenza Vaccine intradermal dose is developed by Seqirus (see full Seqirus pipeline at /company/seqirus).
What development phase is Trivalent Influenza Vaccine intradermal dose in?
Trivalent Influenza Vaccine intradermal dose is in Phase 1.